Creative Biolabs-Immuno-oncology

Anti-DNM1L (clone 3F3) SynExpress E1-Cy2-IR-E Modified CD8+ T cells (CAT#: ITS-1224-CR2185)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DNM1L (clone 3F3). We employs the pGEM (EF1α-Cy2-IRF-EcoRI) vector components and the SynExpress system of the Exons RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DNM1L
Clone
3F3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
EF1α
Effector Gene
IRF
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.87
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving